EN2 is under-expressed in gliomas, and elevated EN2 expression restrains cell multiplication, enhances tumor sensitivity to temozolomide, and blocks tumor cell invasion by repressing MMP9 expression [31]. This evidence concerns the gene MMP9 and central nervous system cancer.